Fluoroclogyline, identified by its CAS number 135062-18-9, is a chemical compound that belongs to the class of monoamine oxidase inhibitors (MAOIs). It is characterized by its fluorinated structure, which enhances its pharmacological properties. This compound is primarily studied for its potential therapeutic applications, particularly in the treatment of neurological disorders such as depression and anxiety. Fluoroclogyline exhibits selective inhibition of the monoamine oxidase enzyme, which is crucial for the metabolism of neurotransmitters like serotonin, norepinephrine, and dopamine. The presence of fluorine in its structure may contribute to increased lipophilicity, potentially affecting its bioavailability and distribution in biological systems. Additionally, its safety profile and side effects are important considerations in its therapeutic use. As with many MAOIs, dietary restrictions may be necessary to avoid hypertensive crises due to interactions with tyramine-containing foods. Overall, fluoroclogyline represents a significant area of research in medicinal chemistry, particularly in the context of developing new antidepressant therapies.

fluoroclorgyline

135062-18-9: Fluoroclogyline, identified by its CAS number 135062-18-9, is a chemical compound that belongs to the class of monoamine oxidase inhibitors (MAOIs). It is characterized by its fluorinated structure, which enhances its pharmacological properties. This compound is primarily studied for its potential therapeutic applications, particularly in the treatment of neurological disorders such as depression and anxiety. Fluoroclogyline exhibits selective inhibition of the monoamine oxidase enzyme, which is crucial for the metabolism of neurotransmitters like serotonin, norepinephrine, and dopamine. The presence of fluorine in its structure may contribute to increased lipophilicity, potentially affecting its bioavailability and distribution in biological systems. Additionally, its safety profile and side effects are important considerations in its therapeutic use. As with many MAOIs, dietary restrictions may be necessary to avoid hypertensive crises due to interactions with tyramine-containing foods. Overall, fluoroclogyline represents a significant area of research in medicinal chemistry, particularly in the context of developing new antidepressant therapies.

Fluoroclorgyline is a specific inhibitor of monoamine oxidase A (MAO-A).

CAS 135062-18-9

fluoroclorgyline

Fluoroclorgyline

Ref: TM-T24069